Travere Therapeutics to Report First Quarter 2026 Financial Results

Go back to Travere Therapeutics to Report First Quarter 2026 Financial Results
(NASDAQ: TVTX) Delayed: 54.81 -0.3 (0.54%)
Previous Close $55.11    52 Week High
Open $54.43    52 Week Low
Day High $55.00    P/E N/A 
Day Low $54.13    EPS
Volume 53,932